Global Neuromodulation Market Research Report: Forecast (2024-2030)

Global Neuromodulation Market Report - By Type (Internal Neuromodulation, (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimul... ... ic Electrical Stimulation), External Neuromodulation, (Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), Respiratory Electrical Stimulation)), By Application (Neuromodulation for Spinal Cord Stimulation, (Chronic Pain, Failed Back Surgery Syndrome (FBSS), Ischemia), Neuromodulation for Deep Brain Stimulation, (Parkinson’s Disease, Tremors, Depression, Others), Neuromodulation for Sacral Nerve Stimulation, (Urine Incontinence, Fecal Incontinence), Neuromodulation for Vagus Nerve Stimulation, (Epilepsy, Others), Neuromodulation for Gastric Electrical Stimulation, (Gastroparesis, Obesity), Neuromodulation for Transcutaneous Electrical Nerve Stimulation (Treatment-Resistant Depression, Others), Neuromodulation for Transcranial Magnetic Stimulation, (Depression, Migraine), Neuromodulation for Respiratory Electrical Stimulation, (Spinal Cord Injury)), and Others Read more

  • Healthcare
  • May 2024
  • 186
  • PDF, Excel, PPT

Market Definition

Neuromodulation is a medical term that refers to the application of stimuli with either thermal, electrical, or chemical signals to alter nerve activity. This methodology helps in improving several neurological disorders amongst patients with diseases like depression, migraine, etc. Several devices are used by healthcare professionals to supply these stimuli to patients' nerves to modulate their neural activity.

Market Insights & Analysis: Global Neuromodulation Market (2024-30):

The Global Neuromodulation Market size is estimated to grow at a CAGR of around 10.3% during the forecast period, i.e., 2024-30. The Global Neuromodulation market has experienced significant growth driven by the increasing instances of cases of neurological diseases like migraine, epilepsy, depression, etc. Also, there is an increasing demand for non-invasive surgical procedures amongst patients, owing to less amount of physical pain related to these methods. Hence, a neuromodulation procedure requires implantable devices and instruments to deliver stimulation to targeted nerves, which further supports the increased adoption of neuromodulation techniques.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-30
CAGR (2024-2030) 10.3%
Regions Covered North America: The US, Canada, Mexico
South America: Brazil, Rest of South America
Europe: Germany, The UK, France, Italy, Spain, Rest of Europe
Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia-Pacific
Middle East & Africa: GCC,  South Africa, Rest of Middle East & Africa
Key Companies Profiled Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, NeuroSigma, Inc., Neuropace Inc., Softerix Medical Inc., Aleva Neurotherapeutics, Synapse Biomedical Inc., Theranica Bio-Electronics Ltd., Neuronetics, Axonics, Inc., Gimer Medical, Nalu Medical, Inc., Helius Medical Technologies, Inc., MicroTransponder Inc., among others
Unit Denominations USD Million/Billion

 

Moreover, the companies in the neuromodulation market have largely focused on increasing investment across research & development in recent years. This increased focus on R&D activities has been mainly driven by the increasing possibility of a rise in neurological disorders in coming years, which would be influenced by a growing number of geriatric population, which prefer non-invasive treatment solutions. Hence, R&D activities have emerged as a recent market trend, which is focusing on improving the application areas of neuromodulation devices. Thus, as neuromodulation devices gain prominence in treating disorders like stroke, obsessive-compulsive disorder, and interstitial cystitis, their demand would amplify further in the coming years. Also, as consumers gain more awareness of neurological disorders, the Global Neuromodulation market is poised for continued growth in the future.

Global Neuromodulation Market Driver:

Increasing Instances of Depression to Drive Market Growth- Globally, there has been a substantial increment in the instances of depression. Initially, with the start of the pandemic situation, and lockdown conditions, the social gatherings of individuals were largely reduced. Hence, they have experienced an increment in social anxiety and depression cases. Also, the global healthcare infrastructure is not advanced enough to cater to the rising demand for mental illnesses. Hence, this has further amplified the instances of these disorders. Consequently, the demand for neuromodulation techniques has increased, as the burden of depression escalated largely in recent years.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Neuromodulation Market Patent Analysis
  5. Global Neuromodulation Market Start-up Ecosystem, 2019-2024
    1. Entrepreneurial Activity
    2. Year-on-Year Funding Received
    3. Funding Received by Top Companies
    4. Key Investors Active in the Market
    5. Series Wise Funding Received
      1. Seed Funding
      2. Angel Investing
      3. Venture Capitalists (VC) Funding
      4. Others
  6. Global Neuromodulation Market Trends & Insights
  7. Global Neuromodulation Market Dynamics
    1. Drivers
    2. Challenges
  8. Global Neuromodulation Market Hotspots & Opportunities
  9. Global Neuromodulation Market Regulations & Policies
  10. Global Neuromodulation Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type
        1. Internal Neuromodulation- Market Size & Forecast 2019-2030F, USD Million
          1. Spinal Cord Stimulation- Market Size & Forecast 2019-2030F, USD Million
          2. Deep Brain Stimulation- Market Size & Forecast 2019-2030F, USD Million
          3. Vagus Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
          4. Sacral Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
          5. Gastric Electrical Stimulation- Market Size & Forecast 2019-2030F, USD Million
        2. External Neuromodulation- Market Size & Forecast 2019-2030F, USD Million
          1. Transcutaneous Electrical Nerve Stimulation (TENS)- Market Size & Forecast 2019-2030F, USD Million
          2. Transcranial Magnetic Stimulation (TMS)- Market Size & Forecast 2019-2030F, USD Million
          3. Respiratory Electrical Stimulation- Market Size & Forecast 2019-2030F, USD Million
      2. By Application
        1. Neuromodulation for Spinal Cord Stimulation- Market Size & Forecast 2019-2030F, USD Million
          1. Chronic Pain- Market Size & Forecast 2019-2030F, USD Million
          2. Failed Back Surgery Syndrome (FBSS)- Market Size & Forecast 2019-2030F, USD Million
          3. Ischemia- Market Size & Forecast 2019-2030F, USD Million
        2. Neuromodulation for Deep Brain Stimulation- Market Size & Forecast 2019-2030F, USD Million
          1. Parkinson’s Disease- Market Size & Forecast 2019-2030F, USD Million
          2. Tremors- Market Size & Forecast 2019-2030F, USD Million
          3. Depression- Market Size & Forecast 2019-2030F, USD Million
          4. Others- Market Size & Forecast 2019-2030F, USD Million
        3. Neuromodulation for Sacral Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
          1. Urine Incontinence- Market Size & Forecast 2019-2030F, USD Million
          2. Fecal Incontinence- Market Size & Forecast 2019-2030F, USD Million
        4. Neuromodulation for Vagus Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
          1. Epilepsy- Market Size & Forecast 2019-2030F, USD Million
          2. Others- Market Size & Forecast 2019-2030F, USD Million
        5. Neuromodulation for Gastric Electrical Stimulation- Market Size & Forecast 2019-2030F, USD Million
          1. Gastroparesis- Market Size & Forecast 2019-2030F, USD Million
          2. Obesity- Market Size & Forecast 2019-2030F, USD Million
        6. Neuromodulation for Transcutaneous Electrical Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
          1. Treatment-Resistant Depression- Market Size & Forecast 2019-2030F, USD Million
          2. Others- Market Size & Forecast 2019-2030F, USD Million
        7. Neuromodulation for Transcranial Magnetic Stimulation- Market Size & Forecast 2019-2030F, USD Million
          1. Depression- Market Size & Forecast 2019-2030F, USD Million
          2. Migraine- Market Size & Forecast 2019-2030F, USD Million
        8. Neuromodulation for Respiratory Electrical Stimulation- Market Size & Forecast 2019-2030F, USD Million
          1. Spinal Cord Injury- Market Size & Forecast 2019-2030F, USD Million
      3. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia Pacific
      4. By Company
        1. Market Share of Top Companies
        2. Competition Characteristics
  11. North America Neuromodulation Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2030F, USD Million
      2. By Application- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. The US
        2. Canada
        3. Mexico
      4. The US Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      5. Canada Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      6. Mexico Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
  12. South America Neuromodulation Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2030F, USD Million
      2. By Application- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. Brazil
        2. Rest of South America
      4. Brazil Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
  13. Europe Neuromodulation Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2030F, USD Million
      2. By Application- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      4. Germany Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      5. The UK Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      6. France Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      7. Italy Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      8. Spain Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
  14. The Middle East & Africa Neuromodulation Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2030F, USD Million
      2. By Application- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. GCC
        2. South Africa
        3. Rest of the Middle East & Africa
      4. GCC Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      5. South Africa Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
  15. Asia Pacific Neuromodulation Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2030F, USD Million
      2. By Application- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. China
        2. Japan
        3. India
        4. South Korea
        5. Australia
        6. Rest of Asia Pacific
      4. China Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      5. Japan Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      6. India Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      7. South Korea Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
      8. Australia Neuromodulation Market Outlook, 2019-2030F
        1. Market Size & Analysis
          1. By Revenues (USD Million)
        2. Market Share & Analysis
          1. By Type- Market Size & Forecast 2019-2030F, USD Million
          2. By Application- Market Size & Forecast 2019-2030F, USD Million
  16. Global Neuromodulation Market Key Strategic Imperatives for Growth & Success
  17. Competition Outlook
    1. Company Profiles
      1. Medtronic Plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Abbott Laboratories
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Boston Scientific Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. NeuroSigma, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Neuropace Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Softerix Medical Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Aleva Neurotherapeutics
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Synapse Biomedical Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Theranica Bio-Electronics Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Neuronetics
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Axonics, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Gimer Medical
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Nalu Medical, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Helius Medical Technologies, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. MicroTransponder Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  18. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization
Related Reports